CRMD Q1 2020 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$74,054-54.8% YoY

Gross Profit

$25,53734.5% margin

Operating Income

-$6M-7577.9% margin

Net Income

-$6M-7504.7% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+198.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$676,614

Balance Sheet

Total Assets

$27M

Total Liabilities

$6M

Stockholders' Equity

$22M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74,054	$163,692	-54.8%
Gross Profit	$25,537	-$63,263	+140.4%
Operating Income	-$6M	-$5M	-14.0%
Net Income	-$6M	-$5M	-7.5%